Correction: From barriers to opportunities from COVID-19 pandemic: Stakeholder perspectives on cervical cancer screening programs in LMICs of the Asia-Pacific region
Jieying Lee, Ida Ismail-Pratt, Dorothy A. Machalek, Suresh Kumarasamy, Suzanne M. Garland
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · Global Cancer Incidence and Screening
The corresponding author’s email address is incorrect. Ida Ismail-Pratt’s email is: [email protected].
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Lee J, Ismail-Pratt I, Machalek DA, Kumarasamy S, Garland SM. From barriers to opportunities from COVID-19 pandemic: Stakeholder perspectives on cervical cancer screening programs in LMI Cs of the Asia-Pacific region. PLOS Glob Public Health. 2024;4(10):e 0003768. doi: 10.1371/journal.pgph.0003768 39365795 PMC 11451976 · doi ↗ · pubmed ↗